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ABSTRACT
Eukaryotes possess a vast array of RNA-binding proteins (RBPs) that affect mRNAs in diverse ways to control
protein expression. Combinatorial regulation of mRNAs by RBPs is emerging as the rule. No example
illustrates this as vividly as the partnership of 3 Drosophila RBPs, Pumilio, Nanos and Brain Tumor, which
have overlapping functions in development, stem cell maintenance and differentiation, fertility and
neurologic processes. Here we synthesize 30 y of research with new insights into their molecular functions
and mechanisms of action. First, we provide an overview of the key properties of each RBP. Next, we
present a detailed analysis of their collaborative regulatory mechanism using a classic example of the
developmental morphogen, hunchback, which is spatially and temporally regulated by the trio during
embryogenesis. New biochemical, structural and functional analyses provide insights into RNA recognition,
cooperativity, and regulatory mechanisms. We integrate these data into a model of combinatorial RNA
binding and regulation of translation and mRNA decay. We then use this information, transcriptome wide
analyses and bioinformatics predictions to assess the global impact of Pumilio, Nanos and Brain Tumor on
gene regulation. Together, the results support pervasive, dynamic post-transcriptional control.
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Introduction
Translation of mRNAs is highly regulated to ensure the proper
quantity, time and location of protein synthesis. The output of
protein from each mRNA is determined in part by its abundance
and the status of the translation apparatus. Information within
the transcript also controls protein expression, including cis-act-
ing regulatory elements, RNA structure, and codon content. Spe-
cific regulatory elements that regulate a transcript’s fate are often
located in 5or 3untranslated regions (UTRs). Many regulatory
elements are recognized by trans-acting RNA-binding factors
that determine whether the transcript is translated or instead
silenced, stored, localized, stabilized or destroyed.
In this review, we explore mechanisms of mRNA regulation by
RNA-binding proteins (RBPs), focusing on 3 now-classic RBPs,
Pumilio (Pum), Nanos (Nos) and Brain Tumor (Brat). To date,
>1500 RBPs have been cataloged and the functions of most
remain to be discovered.1-4 The sheer number of RBPs signifies
the importance of post-transcriptional control. Pum, Nos and
Brat were originally identified in Drosophila decades ago and
remain relevant because they exemplify key principles of post-
transcriptional control and because they regulate crucial biological
functions. Recently, important new insights into their molecular
mechanisms illuminate our understanding of regulated RNA sta-
bility and the spatial and temporal control of protein expression.
Combinatorial control is emerging as a pervasive theme in post-
transcriptional regulation, with mRNAs controlled by a dynamic
constellation of RNA-binding factors. Pum,Nos and Brat represent
an archetypal example where their combined action controls
crucial biologic processes including development, stem cell prolif-
eration, fertility and neurological functions. Genetics revealed over-
lapping functions, and they were shown to physically interact with
each other on a target mRNA, leading to a compelling model some
15 y ago.5-7 Yet the mechanism of combinatorial control was not
well understood. Recent advances provide the detailed molecular
basis of their collaboration. We now understand that Pum, Nos
and Brat proteins each define a protein family with unique modes
of RNA recognition. Certain transcripts can be targeted by all 3
RBPs, which bind cooperatively to synergistically repress protein
expression. Here we introduce the unique features of Pum, Nos
and Brat proteins, and integrate new biochemical, structural and
functional data into an updated model of their combinatorial regu-
latory function. We then explore the implications of this model for
regulation of mRNAs on a transcriptome-wide scale.
Pumilio
Pum is a founding member of the PUF (Pum and fem-3 bind-
ing factor) family of eukaryotic RNA-binding proteins.8 Pum
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was originally identified as a maternal effect gene necessary for
embryonic development.9,10 The name Pumilio is Latin for
“dwarf,” referring to the small embryos from the original pum
mutant. Subsequently, Pum was shown to regulate diverse bio-
logic processes including germline stem cell proliferation, fertil-
ity, neuronal morphology, motor neuron electrophysiology,
and memory formation.11-16
Pum is a 1533 amino acid residue protein with a conserved
Pum homology domain (Pum-HD) located in the C-terminal
third (Fig. 1A). The Pum-HD, which defines the PUF family, is
a sequence-specific RNA-binding domain of »40 kDa com-
posed of repeated triple a helical units.6,17,18 Pum has 8 repeats
that form a crescent shaped molecule, and each repeat presents
3 amino acid residues that recognize a single RNA nucleo-
tide.18,19 Pum thereby binds an 8 nucleotide, single-stranded
RNA sequence with the consensus 5-UGUANAUA (where N
D A, G, C or U), herein referred to as the Pum Response
Element (PRE) (Fig. 1B).19-23 X-ray crystal structures of the
RNA-binding domains of PUF proteins bound to RNA ligands,
including the high resolution structure of Pum bound to a
PRE, clearly illustrate the modular RNA recognition, and recent
reviews provide a comprehensive discussion of the determi-
nants of PUF RNA-binding specificity (Fig. 1C).19,24-26
Pum binds and represses specific mRNAs that contain one or
more PREs, resulting in reduced protein expression and acceler-
ated mRNA degradation.27-30 We now understand that Pum
repression occurs through multiple mechanisms. The Pum-HD
represses by targeting the poly(A) tail of target mRNAs. Nor-
mally, the poly(A) tail acts to promote translation and stability of
an mRNA, mediated by poly(A) binding protein, PABP. We
found that the Pum-HD associates with and antagonizes the
translational activity of PABP, thereby contributing to
Figure 1. Pum, Nos, and Brat are RNA-binding proteins that bind the hunchback mRNA. (A) Schematic diagrams of Pum, Nos, and Brat proteins with relevant domains
labeled: Pum N-terminal Repression Domains (RD1, RD2, and RD3), and Pum Homology Domain (Pum-HD); Nos Effector Domain (NED), Zinc Fingers (Z), and C-terminal
extension (C); Brat B-box Zinc Fingers 1 and 2 (B1 and B2), coiled coil (CC), and NCL-1, HT2A, and Lin-41 (NHL) domain. (B) Pum, Nos and Brat bind to the Nanos Response
Element 2 (NRE2) RNA from the hunchback 3UTR with color-coded binding sites for Brat, Nos, and Pum. Box A and B elements of the NRE are outlined by a black box.
Direct interactions are indicated by solid lines whereas dashed lines indicate putative interactions. The loop between repeats 7 and 8 of Pum, which mediates protein-pro-
tein interaction with Nos, is shown in black. (C) Structural model of Brat (NHL domain), Nos (ZC regions), and Pum (Pum-HD) proteins with NRE RNA. The crystal structures
of Brat in complex with a BBS (red, PDB ID 4ZLR) and Nos (blue)/Pum (yellow) in complex with NBS-PRE RNA (PDB ID 5KL1) are shown with the 4 nucleotide spacer RNA
(gray) present in the native hunchback NRE2 RNA. Brat and Pum proteins are shown as ribbon diagrams. Nos is shown with a molecular surface superimposed. Residue
G1330 of Pum is highlighted by a yellow sphere.
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repression.28 The Pum-HD also directs repression by promoting
removal of poly(A) from target mRNAs by recruiting the Pop2
deadenyase enzyme,28,31,32 which is part of the Ccr4-Not complex
(CNOT) that catalyzes deadenylation and causes translational
repression.33,34 Notably, poly(A)-dependent repression mecha-
nisms are conserved functions of PUF proteins.28,30-32,35,36
Pum also elicits poly(A)-independent repression. In both
cultured cells and embryos, Pum represses reporter mRNAs
lacking a poly(A) tail, albeit with reduced efficiency.28,30,37
Structure-function analysis revealed that the N-terminus of
Pum, wholly outside of the Pum-HD, conferred poly(A)-
independent repression activity.27 The N terminus was
largely a mystery as it is not homologous to other proteins
or domains. However, genetic evidence indeed supports the
importance of the Pum N terminus, as its inclusion in
transgenes was necessary to fully rescue developmental
defects of a pum mutant.[20] Dissection of the Pum N ter-
minus revealed 3 autonomous repression domains capable
of poly(A)-independent repression, potently inhibiting pro-
tein expression and stimulating mRNA decay when targeted
to a reporter mRNA.27 It remains to be determined how
each Pum repression domain operates.
Nanos
Nos is a founding member of the eukaryotic Nos protein fam-
ily, with orthologs found throughout multicellular eukaryotes.
Nos was originally identified as a maternally provided determi-
nant of posterior development.10,38 The name nanos is Greek
for “dwarf” and describes the morphology of original mutant
embryos, which is identical to the pum phenotype.38 In fact,
Nos shares several biological roles with Pum including embry-
onic development, control of germline stem cell proliferation,
neuronal morphology, and long-term memory forma-
tion.11,13,15,16,39 These commonalities are indicative of collabo-
rative control by Nos and Pum.
Nos protein is 401 amino acid residues in length with 2 unique
C-terminal CCHC-type Zinc Finger (ZF) domains that define the
Nanos family (Fig. 1A). The ZF domains were reported tomediate
non-specific binding to RNA.40,41We recently found that Nos ZFs
bind specifically to a Nanos Binding Site (NBS) in RNA, but only
when that RNA includes a downstream PRE sequence that is
bound by Pum (discussed further below) (Fig. 1B).19 Crystal
structures of the ZFs of Nos bound to RNA in conjunction with
Pum provide evidence of specific nucleotide binding pockets
formed by the tandem ZF domains (Fig. 1C).19
Like Pum, Nos is a repressor that reduces protein expression
and stimulates decay of target mRNAs.42,43 Recent research has
revealed that Nos binds and recruits the CNOT complex to
repress translation and elicit decay by promoting deadenylation
and decapping of the 57-methyl guanosine cap structure.44-46
Brain Tumor
Brat is an RBP with important roles in oogenesis, embryogene-
sis and the nervous system.5,47-49 Brat was originally identified
as a growth suppressor in the larval brain, its name derived
from the mutant phenotype wherein neural cells aberrantly
proliferate.48,49 Brat has many documented functions including
regulation of neuromuscular junction formation, neuronal dif-
ferentiation, axon maintenance in mushroom bodies and con-
trol of motor neuron electrophysiology.39,50-52 Brat has
overlapping functions with Pum and Nos in the germline and
embryo, as discussed below, and also has functions indepen-
dent of Pum and Nos.5,52,53
Brat is a 1037 amino acid residue protein that belongs to the
TRIM-NHL class of proteins, which are defined by an N-termi-
nal TRIM (Tripartite Motif) and C-terminal NHL (NCL-1,
HT2A, and Lin-41) domain (Fig. 1A).54 The C-terminal NHL
domain forms a 6-bladed b propeller structure that is crucial
for function.7,48,55 Initially, Brat was thought to function as an
adaptor protein that mediated protein-protein interactions5,7;
however, the NHL domain of Brat was recently shown to be an
RNA-binding domain, specifically recognizing the Brat binding
site (BBS) with consensus 5-WYGUUD (where W D A or U;
Y D U or C; D D G, A, or U) (Fig. 1B and Fig. 1C).29,55,56 The
TRIM region of Brat contains 2 B-box type ZFs, which are
broadly found in DNA- and RNA-binding proteins, but it is
unknown whether these domains contact RNA.
Like Pum and Nos, Brat represses translation from target
mRNAs and accelerates their decay5,29,53; however, less is
known about its mechanism. Evidence from embryos demon-
strates that Brat causes turnover of numerous transcripts dur-
ing the maternal-to-zygotic transition (MZT), a developmental
stage in which maternally provided transcripts are degraded
and zygotic genome transcription is initiated,57,58 and this
effect can be recapitulated in cultured cells with reporter
mRNAs.29,55,56 Brat appears to work in conjunction with the
translational repressor protein, 4EHP (eIF4E homologous pro-
tein); the NHL domain was reported to interact with 4EHP,
and 4EHP mutations reduced Brat-mediated repression.53 Brat
is also reported to associate with the CNOT deadenylase com-
plex,59 suggesting that it may promote deadenylation of
mRNAs, although this supposition remains unproven.
Combinatorial control by Pumilio, Nanos and Brain Tumor:
The hunchback mRNA paradigm
No case better exemplifies combinatorial control by Pum, Nos
and Brat than collaborative regulation of hunchback mRNA,
their first identified target in the early embryo.60-63 Justified by
its biological significance, intense focus on the mechanisms of
hunchback regulation helped to establish key parameters of the
Pum-Nos-Brat partnership.
During early embryogenesis in Drosophila, the zygotic
genome is transcriptionally silent and development is directed by
maternally supplied gene products.57,58 Maternal mRNAs, includ-
ing hunchback, must be precisely regulated for development to
proceed. Hunchback is a transcription factor that controls body
pattern formation, and its expression must be limited to the ante-
rior portion of the syncytial embryo before the MZT.64 Because
hunchback mRNA is distributed throughout the embryo, its
mRNA is translated only in the anterior while being repressed in
the posterior to achieve proper spatial distribution of Hunchback
protein.61,63,65 Repression of hunchback is achieved by Pum, Nos
and Brat, and mutations that inactivate them result in improper
expression of the Hunchback protein in the posterior, subsequent
loss of abdominal segments, and developmental failure.5,9,62,66-68
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The spatial distribution of Hunchback protein is determined
by an opposing concentration gradient of Nos protein.38,61,62,68
nos mRNA is localized to the embryo’s posterior where its
localized translation, coupled to simultaneous repression of
unlocalized nos mRNA in the bulk cytoplasm,69-72 establishes a
Nos protein gradient that is highest in the posterior, quickly
diminishing toward the anterior. Pum and Brat proteins are
distributed throughout the embryo, and although crucial for
hunchback mRNA regulation, they do not provide the spatial
cue.5,66,73 In addition to controlling hunchback translation dur-
ing early embryogenesis, the combinatorial action of Pum and
Brat (and likely Nos) mediates degradation of maternally pro-
vided hunchback mRNA during the MZT.29,65
Early work mapped the features of hunchback mRNA neces-
sary for Nos-mediated repression. Two separate Nanos Response
Elements (NREs) were identified within the hunchback mRNA
3UTR that are necessary and sufficient to confer Nos-mediated
repression in embryos.40,42,74 Each NRE contains 2 distinct, con-
served elements termed Box A and Box B, which are required for
complete regulation (Fig. 1B). These NREs are the nexus for
combinatorial regulation of hunchback mRNA by Nos, Pum and
Brat.
The Nanos Response Element is directly bound by Pumilio,
Nanos and Brain Tumor
A synthesis of early and recent discoveries firmly establishes
direct binding and combinatorial regulation of hunchback
mRNA by Nos, Pum and Brat. Pum was first shown to bind
each NRE element of hunchback.22,74 The Pum-NRE interac-
tion was interrogated through mutational analysis and binding
assays, defining a high affinity PRE within each NRE bound by
a single Pum.21,22 Structural, high throughput selection and
sequencing, and transcriptome-wide analyses corroborated and
defined the specificity of the Pum-PRE interaction.18,19,23 We
now understand that each hunchback NRE contains a single
high affinity 8 nucleotide PRE, the 5 half of which overlaps
with each conserved Box B element (Fig. 1B).
Insight into the role of Nos in hunchback regulation
emerged from structure-function analysis using Nos trans-
genes, which identified the ZFs and C terminus as being critical
for hunchback regulation.40 Purified, recombinant Nos was also
reported to bind the NRE without apparent specificity, though
we now understand that the NRE mutations tested were in fact
outside the Nos binding site.19,40 Key insights into the Nos-
NRE interaction came from yeast 3-hybrid assays, which
showed that Nos binds to the NRE in a Pum-dependent man-
ner, and the resulting ternary complex could also be detected
by in vitro pulldown assays.75 Mutations that disrupt Nos, Pum
or NRE function prevented formation of the ternary complex.
Nos did not bind the NRE in the absence of Pum; however,
when Pum was included, Nos could be crosslinked to the RNA.
Nos did not stably bind Pum in the absence of NRE RNA.
These results indicated that Pum provides sequence-specific
RNA-binding, whereas Nos recognizes a combination of Pum
and RNA. Importantly, nucleotides upstream of the PRE were
shown to be important for incorporation of Nos into this ter-
nary complex.75
We recently reported biochemical, structural and cell-
based studies that show how Nos and Pum cooperatively
bind NRE RNA.19 Using RNA electrophoretic mobility shift
assays (EMSA), we found that Nos tightly binds the
Pum-NRE complex and increases the affinity of Pum for
the NRE, correlating with its ability to enhance translational
repression in cells in a dosage dependent manner. A critical
revelation is that Pum does not merely recruit Nos for
repression activity; Nos enhances the binding of Pum to
hunchback RNA, bringing the combined repressive activities
of Nos and Pum to bear on hunchback mRNA exclusively
in the embryonic posterior where Nos concentration is
highest.19
Our crystal structure of the Nos-Pum-NRE ternary com-
plex illuminated the mechanism of Nos-Pum cooperativ-
ity.19 Pum recognizes the PRE sequence in the recognizably
modular fashion, while Nos embraces both Pum and RNA,
effectively clamping them together (Fig. 1C). The Nos C
terminus interacts with a loop region between the 7th and
8th repeats of the Pum-HD. Conformational changes in the
loop of Pum are induced by the Nos interaction, which ena-
bles an a helix at the C terminus of the Pum-HD to unfold
and contact the NRE. Mutational analysis affirmed the
importance of observed interactions for complex formation
in vitro and repression activity in cells.19 The observed con-
tacts also illustrate how mutants of Pum (mutations in the
loop between repeat 7 and 8), Nos (mutations in the ZFs or
C terminus) and Box B of the NRE result in loss of hunch-
back mRNA regulation in embryos.20,38,42,68
Our Nos-Pum-NRE structure revealed that the tandem ZFs
of Nos bind 3 nucleotides immediately upstream of the PRE,
defining the NBS (Fig. 1B).19 By performing Nos-Pum selection
of a randomized RNA library and high throughput sequencing
(SEQRS), we showed that Nos confers specificity for A/U rich
NBS sequences in the presence of Pum.19,76 Nos-NBS specificity
is verified in cells and embryos, where mutations of the NBS
prevent Nos-mediated repression.19,20,42,74 Together, these data
support a model wherein Nos acts as a clamp that promotes
the binding of Pum to the NRE, and together they recognize an
extended NBSCPRE sequence encompassing the Box B region
of the NRE (Fig. 1C). In turn, the ternary complex elicits robust
repression of hunchback mRNA.
Brat was identified as a third protein recruited by the
Nos-Pum-NRE ternary complex.5 Using a yeast 4-hybrid
strategy, the Brat NHL domain was found to bind the Pum-
Nos-hb NRE complex. Yeast interaction and in vitro pull-
down assays indicated that Nos and Pum were both needed
to recruit Brat to the NRE. Yet no direct interaction of Brat
with NRE, Nos or Pum individually could be detected by
these means. A model was put forth wherein Pum and Nos
bind the NRE and then recruit Brat through simultaneous
protein-protein interactions with Nos and Pum to form a
quaternary complex.5-7 Genetic analysis showed that brat
mutants disrupted hunchback mRNA regulation and abdom-
inal segmentation in embryos, mirroring the effects of Nos,
Pum or NRE mutants.5,53
New data on Brat’s RNA-binding properties and its interac-
tion with the NRE warrant a re-evaluation of the quaternary
complex model. Three studies have now shown that Brat is an
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RNA-binding protein that directly contacts the Box A sequence
in each hunchback NRE (Fig. 1B).29,55,56 A crystal structure of
the Brat NHL domain bound to RNA revealed an electroposi-
tive surface of the NHL domain that recognizes the 6 nucleo-
tide, single-stranded RNA element, and mutation of observed
Brat-RNA contacts (including R875A, F916A, and N933A) dis-
rupted its RNA-binding and cellular repression activities.55,56
Based on these data, it is now apparent that Brat does not
require Pum and Nos to bind the NRE. Although Brat and
Pum are able to bind to the NRE cooperatively,55 it is unclear
whether protein-protein interactions underlie this cooperative
binding, since a Brat-Pum interaction could not be detected in
the absence of NRE RNA.55 One proposal is that cooperative
Brat-NRE-Pum binding is mediated by changes in RNA sec-
ondary structure induced by protein-RNA contact.56 More
importantly, it remains uncertain whether the observed cooper-
ative binding even impacts repression activity, since synergism
between Brat and Pum has not yet been demonstrated.55
New insights from structure-function analyses also prompt
reassessment of the effects of specific mutations on the quater-
nary complex, as summarized in Table 1. For example, Pum
mutants C1365R, T1366D, or N1368S were reported to disrupt
Brat recruitment,6 but the Nos-Pum-NRE structure shows that
these residues are at the Nos-Pum interface, and thus are
unlikely to interact with Brat in a quaternary complex.19 Pum
mutant G1330D, which is located in a loop between repeats 6
and 7 of the Pum-HD (Fig. 1C), does not affect RNA binding
or cellular repression activities.5,27 Moreover, G1330D does not
contact Nos in the ternary complex structure, nor does it com-
promise Nos-Pum synergy (Fig. 1C).19,27 Instead, G1330D was
proposed to mediate Brat-Pum interaction,5-7 but no assay has
detected this putative protein-protein interaction and its effect
on cooperative RNA binding by Pum and Brat has not been
evaluated.
Nos was previously thought to be necessary for Brat recruit-
ment to the NRE,5 but direct binding of Brat to Box A obviates
that conclusion. Moreover, the Nos mutant M378K (referred to
as M379K in the original study) prevented Brat recruitment,
but the Nos-Pum-NRE ternary complex revealed that this resi-
due is at the interface of the Nos-Pum interaction and is neces-
sary for Nos-Pum synergism.19,27 The potential influence of
Nos on Brat-NRE interaction remains to be re-evaluated con-
sidering this new information. What effect might Nos have on
the Brat-NRE-Pum interaction? Since Nos enhances Pum affin-
ity for the NRE, and Pum and Brat cooperatively bind the NRE,
we speculate that Nos may enhance the Brat-NRE interaction
acting through Pum. If true, this potential mutual cooperativity
would be expected to contribute to spatiotemporal control of
hunchback mRNA.
Several Brat mutations were originally attributed to disrupt
protein-protein interactions with the ternary complex.5 Instead,
new information shows that these Brat mutations negatively
affect its ability to bind RNA, including H802L (bratFS3 allele)5
and 3 residues located on the “top” electropositive interface
(Y829A, R847A, R875A)(Table 1).7,55,56 With the exception of
H802, the crystal structure of a Brat-RNA complex shows that
these mutated residues line the RNA-binding interface.55,56
Using current information, we illustrate a model of the qua-
ternary complex on the hunchback NRE RNA (Fig. 1C). The
model depicts interaction of the Brat NHL domain with its
binding site overlapping Box A, the contacts of the Pum-HD
bound to the PRE and the Nos-NBS interactions.19,56 From a
structural standpoint, it is not possible to dock the proteins
consistent with the proposed Brat-Pum contacts. First, the
Nos-Pum interface occludes the previously proposed interac-
tion site for Brat on Pum.7 As mentioned above, the previously
modeled Brat-Pum interface is now known to be the RNA-
binding interface. Moreover, the intervening 4 nucleotides
between Box A and the NBS-PRE do not provide enough dis-
tance to permit interaction between the Brat NHL domain and
Pum G1330 (Fig. 1C). Multiple features are missing from this
model including the N termini of Brat, Nos and Pum, for which
structural information is currently not available. Future bio-
chemical and structural analyses are necessary to provide a
more complete understanding of the quaternary complex
architecture.
Multiple mechanisms of synergistic repression by Pumilio,
Nanos and Brain tumor
Why are 3 repressors necessary to regulate hunchback mRNA?
Redundancy is a possibility, but the fact that Pum, Nos and
Brat are all required in vivo argues against that explanation.
Instead, 4 principles have emerged. First, cooperative RNA
binding contributes to the observed synergistic regulation
through increased RNA affinity and specificity, as documented
Table 1. List of documented Pum, Nos, and Brat mutants which disrupt protein-protein and protein-RNA interactions, comparing the interpretations from the “Original
Model” relative to the “New Model” based on recent studies, as cited in the table.
Protein Mutation Original Model New Model Reference
Pum G1130D Binding to Nos-Pum-NRE Unknown 5
Pum C1365R Blocked binding to Nos-Pum-NRE Located at the interface of Nos-Pum, predicted to disrupt binding to Nos 6,19
Pum T1366D Blocked binding to Nos-Pum-NRE Located at the interface of Nos-Pum, predicted to disrupt binding to Nos 6,19
Pum N1368S Blocked binding to Nos-Pum-NRE Located at the interface of Nos-Pum, predicted to disrupt binding to Nos 6,19
Nos M378A or K Blocked binding of Brat to Nos-Pum-NRE Necessary for Nos-Pum binding to NRE 5,19,27
Bratfs1 G774D Blocked binding to Nos-Pum-NRE Effect on NRE binding unknown. Reported to disrupt Brat binding to Mira. 5,50,56
Bratfs3 H802L Blocked binding to Nos-Pum-NRE Reduced affinity for NRE, but does not directly contact RNA 5,55,56
Brat Y829A Blocked binding to Nos-Pum-NRE Reduced binding to NRE 7,55,56
Brat R847A Blocked binding to Nos-Pum-NRE Reduced binding to NRE 7,55,56
Brat R875A Blocked binding to Nos-Pum-NRE Blocked binding to NRE 7,55,56
Brat G860D Disrupt 4EHP interaction 53
Brat K809A/E810A Disrupt 4EHP interaction 53
Brat K882E Disrupt 4EHP interaction 53
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for Nos and Pum.19,27 Whether cooperative RNA binding by
Brat and Pum also contributes to synergism remains unknown.
Second, each regulator is independently capable of repression,
and therefore their collaborative regulation provides multiple
repression mechanisms that inhibit translation and accelerate
mRNA decay. Pum can repress PRE-containing mRNAs inde-
pendent of Nos or Brat.27 Brat can repress mRNAs bearing BBS
motifs independent of Nos and Pum.55,56 Nos also possesses its
own repression activity, as demonstrated by artificial tethering
Nos directly to mRNA31,44; however, in the natural context, it
requires Pum.19,27 Acting together, the combined activities of
Brat, Nos and Pum offers increased magnitude of repression, as
shown by synergistic repression by Nos and Pum,19,27 though
synergism between Brat and Pum has not been demonstrated.55
The third principle is that the repressors each contact specific
subunits of the same effector complex, as described for the
CNOT complex below, resulting in enhanced recruitment to
the target mRNA. A fourth principle is that collaboration
imparts versatility in the means of controlling protein expres-
sion. For instance, repression of Hunchback protein synthesis
is caused by translational inhibition and deadenylation early in
embryogenesis followed by hunchbackmRNA degradation dur-
ing the MZT.29,37,43,65
Collaborative repression by Pum, Nos and Brat is medi-
ated through multiple mechanisms, as shown in Fig. 2.
Repression of translation by Pum, Nos and Brat is caused
by inhibition of both 5 cap and poly(A)-mediated transla-
tion (Fig. 2A). First, Pum antagonizes the translational
activity of PABP; PABP interference has been demonstrated
in cellular repression assays,28 but the use of this poly(A)-
mediated mechanism in the embryo must be verified. Sec-
ond, Brat recruits 4EHP, which inhibits translation by dis-
placing eIF4E from the 5 cap structure.53 Supporting this
mechanism, the cap binding activity of 4EHP is required in
vivo. However, it is important to note that mutation of
4EHP reduces, but does not eliminate, repression of Hunch-
back expression in vivo,53 consistent with multiple repres-
sion mechanisms. Brat mutants (G860D, K809A/E810A,
R837D, K882E) that prevent 4EHP recruitment were identi-
fied, and Brat R837D or K882E did not repress hunchback
mRNA in embryos.53 In cellular repression assays, however,
the Brat R837D mutation had no effect, providing conflict-
ing information about the importance of 4EHP recruitment
for Brat-mediated repression in all contexts.55 Third, Nos
causes translational repression in cell-based assays via a
Nos Effector Domain (NED) in the protein’s N terminus.44
The mechanism of this Nos-mediated translational repres-
sion is currently unknown, but might involve the action of
CNOT complex and associated translational repressors 4E-
T and Me31B (homolog of mammalian DDX6).77-79
Pum, Nos and Brat also accelerate mRNA decay through
multiple mechanisms, with collaborative recruitment of the
CNOT complex emerging as a central theme.27-30,42,43 Both
Nos and Pum promote deadenylation by recruiting the
CNOT complex,28,31,44-46 The Pum-HD binds the Pop2
deadenylase subunit,28,30-32 whereas the Nos NED contacts
Figure 2. Multiple mechanisms of repression by Pum, Nos, and Brat. (A) Translational repression of target mRNAs can be mediated through recruitment of alternative cap-
binding protein 4EHP by Brat, which is proposed to prevent binding of eIF4F translation initiation complex to the 5cap structure (7-methyl guanosine 5-5triphosphate,
m7Gppp). In addition, Pum antagonizes the translation activity of Poly(A) binding protein (PABP). (B) mRNA decay can be initiated through recruitment of the Ccr4-NOT
(CNOT) complex, which catalyzes deadenylation and promotes decapping of the target mRNA. Pum recruits the Pop2 deadenylase to stimulate deadenylation, and Nos
directly recruits Not1 and Not3 of the CNOT complex to stimulate deadenylation and decapping. Solid lines indicate documented interactions whereas dashed lines indi-
cate putative interactions.
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the CNOT1 and CNOT3 subunits.44 Brat also associates
with the CNOT complex,59 but the contacts and its effect
on deadenylation remain to be determined. When combined
on NRE-containing mRNA, Brat, Nos and Pum may syner-
gistically enhance deadenylase recruitment, resulting in
accelerated deadenylation and subsequent mRNA decay.33
To test this prediction, the contributions of the individual
RBP-CNOT contacts on decay of hunchback mRNA should
be evaluated in embryos. Nos also accelerates 5 decapping
(Fig. 2), and inactivation of the decapping enzyme Dcp2
blocked Nos-mediated mRNA decay, as did depletion of
CNOT3.44 It remains unclear whether Nos directly contacts
the decapping enzyme. Alternatively, Dcp2 may be linked
to Nos through the CNOT complex, which associates with
decapping factors.78,79
Additional repression mechanisms appear to contribute
to the repression of hunchback mRNA. For instance, we
identified 3 repression domains (RDs) in the N terminus of
Pum, each of which potently represses translation and pro-
motes mRNA decay in cell-based assays.27 Although the
cofactors necessary for the activity of the Pum RDs must be
identified, PABP and poly(A) are not essential for their
activity.28 Future research will focus on the mechanism of
Pum RD repression and how they contribute to synergistic
regulation to ensure proper spatial and temporal control of
Hunchback protein expression.
Global impact of Pumilio, Nanos, and Brain Tumor on gene
expression
With our new understanding of combinatorial control by Brat,
Nos and Pum, it is now possible to survey their potential
impact on the transcriptome (and thus proteome), both indi-
vidually and collaboratively. Here we integrate experimental
and transcriptome-wide predictions, revealing broad potential
impact on gene expression. Target mRNAs fall into several cat-
egories (Fig. 3) including those individually targeted by Brat or
Pum, jointly targeted by Brat and Pum, jointly targeted by Nos
and Pum, and combinatorially controlled by all 3 RBPs.
To begin, we integrated experimental evidence from several
transcriptome-wide studies that used RNA-protein coimmuno-
precipitation with microarray (i.e. RIP-Chip) to identify
mRNAs bound by Pum and Brat. Unfortunately, no such data
set exists for Nos. Gerber et al. identified mRNAs enriched by
epitope-tagged Pum-HD purified from embryos or adult ova-
ries,23 and Laver et al. performed RIP-Chip of endogenous
Pum from early embryos.29 Together, 1163 Pum-associated
mRNAs were reported; of these, 679 have a consensus PRE.
Laver et al. also identified mRNAs that copurified with endoge-
nous Brat from early embryos, and Loedige et al. identified
mRNAs enriched by epitope-tagged Brat purified from late-
stage embryos.29,56 When combined, 3601 mRNAs were associ-
ated with Brat, with 605 shared between data sets, and 3117
mRNAs contain a BBS. Together, this evidence indicates wide-
spread targeting of mRNAs by Pum or Brat, a conclusion that
is bolstered by the fact that Pum and Brat repress translation
and promote decay of many mRNAs during embryogenesis.29
Comparison of the Pum- and Brat-bound mRNAs reveals
an overlap of 484 mRNAs, indicating the potential coregulation
of many mRNAs. Functional assays lend support for dual regu-
lation of several mRNAs by Brat and Pum.29,55,56 For example,
the dMyc mRNA, which contains 6 PREs and 46 BBS motifs, is
repressed by Pum and Brat in the differentiating cystoblast and
in cellular repression assays, where Nos is absent.56,80 However,
since the majority of targets identified for each regulator did
not overlap, Loedige et al and Laver et al (2015) concluded that
Brat and Pum individually regulate most of their respective tar-
get mRNAs. It is noteworthy that these analyses focused on the
early embryo and adult female germline and likely miss targets
in different tissues and life stages, such as the nervous system,
where Pum and Brat have documented roles.13,15,39,48,50-52,81-86
To survey the genome-wide regulatory potential of each
RBP, we searched the 3UTRs of all Drosophila mRNAs for
potential binding sites. The results are summarized in Table S1,
including number and location of each predicted binding site
in annotated 3UTRs isoforms (the numbers of sites cited in the
text pertain to the longest isoform of unique genes). The PRE
consensus 5-UGUANAUA was derived from multiple
approaches, including SEQRS, RNAcompete, and RIP-Chip,
and validated by EMSA and structural analyses.3,19,23,25,29,87 In
total, 2477 mRNAs possess one or more PREs in their 3UTR,
including many potential targets with interesting biological impli-
cations. The mRNA encoding the antiproliferative protein, Tob,
contains the highest number of PREs, with 12 found in its 3UTR.
The second and third highest number of PREs were in the cpx
mRNA (11 PREs), encoding a protein involved in synaptic trans-
mission, and eag mRNA (9 PREs), encoding a voltage gated
potassium ion channel that controls neuronal excitability.
Figure 3. Classification of Pum, Nos, and Brat target mRNAs. Classification of target
mRNAs regulated by Pum, Nos, and/or Brat, based on experimental evidence and
bioinformatics analysis of Drosophila 3UTRs using RNA-binding affinity, specificity,
and cooperativity. Brat Binding Site (BBS), Pum Response Element (PRE), relaxed
PRE (rPRE), and Nos Binding Site (NBS), described in the text, are indicated for
each of 6 categories.
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We used the consensus BBS, 5-WYGUUD, derived from
RIP-Chip and RNAcompete analyses and supported by EMSA
and structural analyses,29,55,56 and found that 9018 mRNAs
contain at least one BBS. Note that we opted to include a C at
nucleotide position 2 of the BBS search motif to be inclusive of
the functional BBS of hunchback NRE1, which contributes to
regulation55 in vivo, though it is reported to be lower affinity
relative to the BBS in NRE2.55 Of all mRNAs containing BBS
motifs, the mei-P26 mRNA, which encodes another TRIM-
NHL tumor suppressor involved in germline differentiation,
contains the most at 76 potential sites. Brat mRNA contains
the second highest number with 70 BBS motifs, supporting the
potential for autoregulation, as suggested by Laver et al, 2015.
Interestingly, the smooth mRNA, encoding a regulator of axon
guidance, has 66 BBS sites.
A consensus binding site has not been found for Nos alone,
despite our attempts.19 Instead, Nos requires Pum for specific
binding to RNA, and we identified a consensus NBS, encom-
passing 4 nucleotides upstream of the PRE, using SEQRS and
corroborated by EMSA, Nos-Pum-RNA structures, and func-
tional assays.19 Nos binding to the NBS enhances binding of
Pum to “perfect” consensus PREs, 5’-DDWWUGUANAUA
(NBSCPRE), including those in the hunchback NREs. Some
1077 mRNAs have a 3UTR with a NBSCPRE, with the cpx (8
motifs), tob (7 motifs), and kruppel (5 motifs) mRNAs contain-
ing the highest number of these motifs (Table S1).
Additionally, Nos enables Pum binding to “relaxed” PRE
sites (rPRE), wherein nucleotides in position 5-8 of the PRE
do not match the consensus (NBSCrPRE: 5’-DDWWU-
GUA).19 This category includes Nos-Pum targets bicoid and
Cyclin B and was validated by SEQRS, EMSA, a Nos-Pum-
Cyclin B RNA crystal structure and cellular repression
assays.16,19,31,42,88 NBSCrPREs are present in 6225 mRNAs
(Table S1). The mei-P26 mRNA contains 47 such motifs in
its 3UTR, consistent with its CNOT-dependent repression
by Nos and Pum in germline stem cells.46 The smooth
mRNA has the second most NBSCrPREs (41 motifs), sug-
gesting a possible relationship of Pum and Nos to axon
guidance. The longest brat mRNA isoform has 36
NBSCrPRE motifs (and no perfect PREs), which likely
underlie the ability of Nos and Pum to repress its transla-
tion in germline stem cells.80 We also analyzed the Pum-
bound target mRNAs for the presence of these motifs and
found significant enrichment: 56% have a PRE, 79% have
NBSCrPRE and 28% have NBSCPRE (p values < 0.002)
relative to 19%, 52% and 8%, respectively, for all 3UTRs.
Based on these data, we predict that Nos expands the regu-
latory potential of Pum. In summary, our global target pre-
dictions suggest that regulation by Pum, Nos and Brat is
pervasive.
We next asked how many transcripts may be combinatori-
ally regulated by Brat and Pum and found that 2124 mRNAs
possess both BBS and PRE motifs. In only 182 of these mRNAs,
a BBS is located 1-13 nucleotides upstream of a PRE
(BBSCPRE) (Table S1), the range of separation found in veri-
fied targets that are jointly regulated by Brat and Pum. We also
assessed how many mRNAs possess binding sites for Brat, Nos
and Pum and found that 1858 mRNAs possess at least one
binding site for each protein within the 3UTR (Table S1). The
paralytic (para) mRNA, a known target of Brat, Nos and Pum
belongs to this category.39,89 Para encodes a sodium ion chan-
nel that functions in the larval motor neurons and its longest
3UTR has one PRE, 26 NBSCrPRE sites and 19 BBS motifs. In
fact, many of the predicted targets have the potential to be com-
binatorially regulated: nearly 81% of 3UTRs with PRE or
NBSCrPRE/PRE sites also possess BBS motifs, and reciprocally,
66% of 3UTRs with BBS motifs also contain a PRE or
NBSCrPRE/PRE. However, if we restrict the distance between
the BBS and PRE motifs to <13 nucleotides, as is the case in
the hunchback NREs, only 24% of 3UTRs with PRE or
NBSCrPRE/PRE sites also possess an upstream BBS motif and
only 19% of 3UTRs with BBS motifs also contain a downstream
PRE or NBSCrPRE/PRE. Together, these results indicate that
collaborative regulation of many mRNAs is possible, but the
extent depends on the importance of proximity of the RBP
binding sites. Interestingly, only 63 mRNAs have a BBS located
upstream (< 13 nucleotides between BBS and PRE) of a
NBSCPRE (a perfect NRE), and, most surprisingly, the only
target with more than one such perfect NRE motif is hunch-
back, perhaps making it the most sensitive to Nos-Pum-Brat
cooperative regulation (Table S1). The other genes in the per-
fect NRE category are enriched for gene ontologies of signal
transduction (such as tolloid, rhomboid and Ric) and transcrip-
tion (such as knirps, sex combs reduced, clock, and drop).
Indeed, knirps mRNA is bound and repressed by Pum and
Brat.29,56 The tolloid mRNA has 3 BBS motifs in the context of
a perfect NRE and encodes a metalloprotease that promotes
Decapentaplegic (Dpp) signaling, which controls dorsal embry-
onic development and germline stem cell maintenance.90-92 In
addition, the pum mRNA contains a perfect NRE, supported
by binding data, suggesting a means of feedback to regulate the
regulator.23,29 Overall, these results suggest that combinatorial
regulation by Pum, Nos and Brat could impact many tran-
scripts and biological processes, but functional analysis is essen-
tial to determine if cooperative RNA binding and synergistic
repression are widespread.
These binding site predictions are informative and can stim-
ulate future investigations, but have limitations that are impor-
tant to acknowledge. Regulation will be affected by parameters
that we cannot yet integrate, including the level, timing, and
cell type expression of each RBP in vivo. Nos is a prime exam-
ple. Nos is predominantly expressed in the adult ovary and
early embryo,93 though it also has documented roles in neu-
rons.13,39,82,94 Regulation of Cyclin B mRNA provides an exam-
ple of cell type specific regulation.31 Nos and Pum repress
Cyclin B in primordial germ cells, which have a high concentra-
tion of Nos. The Cyclin B 3UTR has no perfect PRE, but instead
it possesses 5 NBSCrPRE motifs that confer regulation. Cyclin
B also has 7 BBS motifs, but since Brat is absent in primordial
germ cells, they are irrelevant for regulation in this cell type.
Mei-P26 mRNA is another example of cell-type specific regula-
tion.46 As noted above, its 3UTR contains both perfect PREs
and many NBSCrPREs, and it is repressed by Pum and Nos in
germline stem cells. Despite its many BBS elements, mei-P26
mRNA is not likely affected by Brat in germline stem cells, as
brat mRNA itself is repressed in this cell type by Nos and Pum
via multiple NBSCrPREs.80 The expression pattern of the pre-
dicted targets will also determine whether they are regulated by
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Brat, Pum, and/or Nos, dictated by coincidence of target and
regulator expression. In the example of hunchback, its mRNA
is most highly expressed in early embryo and adult female
ovary, coincident with high expression of Pum, Nos and
Brat.65,66,68,73,93
The effect of the number, affinity, location, and spacing of
each binding site is also not fully known. For our survey, we
required that at least one binding site is present in the putative
target. Indeed, for Nos and Pum, reporter assays indicate that
one PRE or NBSCrPRE is sufficient to confer repression, and
increased number and affinity of binding sites correlates with
stronger repression.19 For Brat, one binding motif can by recog-
nized by the protein, but 2 BBS motifs in the same RNA were
bound more tightly.55 Moreover, in cellular repression assays,
multiple BBS motifs conferred regulation by Brat, with 2 motifs
being the minimum tested.29,55 The relative orientation of the
binding sites is also likely relevant. For Nos-Pum targets, the
NBS must be directly upstream of the PRE.19 For Brat-Pum tar-
gets, we allowed up to 13 nucleotides of separation between
BBS and PRE, a parameter that is consistent with validated tar-
gets. The impact of the proximity of the BBS to an NBS or PRE
is not known, although it is likely to affect collaboration. Based
on cellular repression assays with reporter mRNAs, other spac-
ing and arrangements of BBS and PRE motifs may be permissi-
ble for Brat or Pum-mediated repression,56 but no data are
available regarding cooperative RNA binding or synergistic
repression.
RNA structure is likely to influence accessibility of the
predicted binding sites, but how this parameter affects bind-
ing and regulation by Pum, Nos and Brat remains uncer-
tain. Since each RBP binds a single-stranded RNA motif,
structure may occlude or reduce binding affinity; however,
evidence indicates that mammalian Pum proteins can dis-
rupt double-stranded RNA to gain access to a PRE.95,96
RNA binding by the Brat NHL domain was reduced when
the BBS motif was within a stem loop of an RNA ligand
that also contained a PRE, and addition of Pum strength-
ened binding, perhaps promoted by Pum’s ability to disrupt
RNA structure.56 The ability of Nos and Pum to bind struc-
tured RNA cooperatively remains untested. Because of these
remaining questions and lack of information on the effect
of RNA structure on regulation in vivo, and the difficulties
of accurately predicting RNA structure, we did not incorpo-
rate RNA structure predictions into our analysis at this
time. Future research should address the relationship of
RNA structure to binding and regulation of RNAs by Nos,
Pum and Brat.
Alternative 3 end processing of mRNAs could impact
regulation by Brat, Nos and Pum in cases where their bind-
ing sites are altered. The hid mRNA, which is regulated by
Nos and Pum in neurons,94 is an example where 2 mRNA
isoforms are produced by alternative 3 end processing
(Table S1): the hid-RA mRNA has a long 3UTR with multi-
ple NBSCPREs that is regulated by Nos-Pum, whereas these
sites are eliminated in the shorter hid-RB version. Alterna-
tive processing of para mRNA produces 3 3UTR isoforms:
the longest has one perfect PRE, 26 NBSCrPRE motifs and
19 BBS motifs; the medium length isoform has multiple
NBSCrPREs but no PRE; and the short isoform lacks these
sites altogether. Intriguingly, regulation of para depends on
Brat in certain neuronal subtypes but not others, perhaps
the result of alternative processing of the 3UTR or on dif-
ferential expression of Brat.39 In the case of hunchback
mRNA, alternative 3end processing is developmentally reg-
ulated to produce 2 mRNA isoforms: a long 3UTR present
on the zygotically-expressed hunchback-RA mRNA and a
short 3UTR on the maternally-provided hunchback-RB iso-
form in early embryos. Importantly, each isoform contains
both NRE elements.
Conclusion
With the revelation of many uncharacterized RBPs,1-4 future
studies are necessary to analyze their individual regulatory
activities, RNA-binding specificities and target mRNAs.
However, as exemplified by Pum, Nos and Brat, to succeed
in understanding post-transcriptional regulatory networks,
it is imperative to address combinatorial control. Control
by the many more uncharacterized RBPs will likely involve
cooperative RNA binding, altered specificity, and the inter-
play of multiple regulatory mechanisms that contribute to
synergistic regulation or even bifunctional switches.35,97 We
have learned a great deal about the functions of Pum, Nos
and Brat mediated regulation, but important challenges
remain, including identification of combinatorially regulated
mRNAs on a global scale, comprehensive dissection of the
protein interaction network between the trio of RBPs and
their corepressors, and interrogation of the multiple repres-
sion mechanisms in vivo. Future work should also extend
the paradigms of Drosophila Pum, Nos and Brat to investi-
gate the targets, RNA and protein interactions, and regula-
tory mechanisms of their mammalian homologs. Ultimately
these efforts should uncover more of the underlying code of
combinatorial regulation by RBPs.
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